Richard Paxman, CEO of Paxman Scalp Cooling, shares his exporting journey.
Huddersfield-based medical technology company Paxman leads the Scalp Cooling sector. they manufacture and supply the Paxman Scalp Cooling System (PSCS) to over 60 markets worldwide.
Paxman’s device helps patients reduce the side effects of chemotherapy-induced alopecia (CIA). This side effect is often seen as one of the most traumatic parts of cancer treatment.
Paxman has a research centre at the University of Huddersfield. They aim to commercialise two new products in the next 12-24 months.
They export to 60 markets globally, with offices in Canada, Sweden and the USA. Regional managers are also based in France, India, Spain and Singapore.
The USA remains a key focus for the business. However, Asia will become more significant in 2024, with a potential launch in China afterward.
I am incredibly passionate about exporting and strongly believe it can be the answer to growth and improved productivity. Export is 90% of our business and the USA is 50% of our total business. Our vision is that no matter where in the world you are, no matter who you are, nor your financial position, you have access to our technology. For me, the top tip is that export is all about relationships. Ensure you understand the market, the people, the place, the regulatory environment and how you will get paid. The best way to do this is by getting on a plane, visiting the market, and beginning to build relationships. We often joke in my international team #ToGrowWeMustFly.
Richard Paxman, CEO
Paxman Scalp Cooling
Business support and case study provided by the Department for Business and Trade.
